Iqbal S. Grewal
Position
- CSO, ImmunGene Inc.
- Vice President, Preclinical Therapeutics, Seattle Genetics Inc.
Education
- D.Sc. (Doctor of Science), University of Aberdeen, United Kingdom
- FRCPath, Fellow Royal College of Pathologists, The Royal College of Pathologists , London
- Ph.D. in Immunology, UCLA
- M.S. in Immunobiology, University of Aberdeen, United Kingdom
- B.S. in Biology and Chemistry, Panjab University, India
Experience
- Joined Seattle Genetics Inc. in October 2004
- Manages the company’s molecular oncology and immunology, translational biology and pharmacology and toxicology functions, including the planning and execution of studies to advance preclinical programs and support clinical development activities
- Worked with Genentech as a Senior Scientist in the Department of Immunology
- Joined Genentech in May 1998
- Worked at the Yale University School of Medicine
- Has held various research positions at the University of California, Los Angeles (UCLA)
- Has published over 100 manuscripts and co-authored several patent applications
- He is serving on editorial boards of journals and has edited books on biotherapeutics
- He is serving on Board of Directors for ImmunGene Inc.
